These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 14581310)

  • 1. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update.
    Genest J; Frohlich J; Fodor G; McPherson R;
    CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical practice guidelines for the management of dyslipidemia.
    Nichols N
    Can J Cardiovasc Nurs; 2004; 14(2):7-10. PubMed ID: 15230023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES].
    Agence Nationale d'Accréditation et d'Evaluation en Santé
    J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dyslipidemia, diabetes and cardiovascular disease].
    Hansen CN; Jensen TJ; Borch-Johnsen K
    Ugeskr Laeger; 2000 Aug; 162(33):4367-70. PubMed ID: 10962957
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular risk factors in adolescents: relevance, detection, and intervention.
    McCrindle BW
    Adolesc Med; 2001 Feb; 12(1):147-62. PubMed ID: 11224028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of firefighters' cardiovascular disease-related knowledge and behaviors.
    Kay BF; Lund MM; Taylor PN; Herbold NH
    J Am Diet Assoc; 2001 Jul; 101(7):807-9. PubMed ID: 11478481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 11. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 13. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG; Tanuseputro P; Mustard CA; Schultz SE; Anderson GM; Ardal S; Alter DA; Laupacis A
    CMAJ; 2005 Apr; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of patients with high cardiovascular risk in general practice].
    Ilyés I; Erdei I; Jancsó Z
    Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478
    [No Abstract]   [Full Text] [Related]  

  • 15. Common questions in managing hyperlipidemia.
    Rosen IM; Sams RW
    Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid-lowering therapy in chronic kidney disease].
    Fernández-Vega F
    Nefrologia; 2004; 24 Suppl(6):113-26, 187-235. PubMed ID: 15696902
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
    Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
    CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypertriglyceridemia and cardiovascular disease management.
    Codario RA
    J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for the prevention and treatment of atherosclerosis and cardiovasculer diseases: treatment of diabetes mellitus, dyslipidemia and the prevention of stroke].
    Bitzur R; Harats D; Rubinstein A
    Harefuah; 2005 Sep; 144(9):647-54, 675. PubMed ID: 16218538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.